Comparisons10 min readUpdated 2026-05-04

    Cheapest Way to Get Tirzepatide in 2026

    The honest cheapest way to get tirzepatide in 2026: compounded tirzepatide telehealth at $125/mo flat (Trimi). Compared to brand Mounjaro/Zepbound ($1,000+/mo), insurance routes, and other telehealth providers.

    Quick Answer

    The truthful answer in 2026: the cheapest legal way to get tirzepatide is compounded tirzepatide through a flat-fee telehealth provider. Trimi at $125/month is the lowest-cost option that still uses board-certified providers and 503A sterile compounding pharmacies. Brand-name Mounjaro/Zepbound costs $1,000-$1,200/month without insurance.

    The 4 ways to get tirzepatide ranked by total cost

    Listed cheapest to most expensive:

    All tirzepatide access routes (May 2026):

    Compounded telehealth (cheapest)$125-$398/moTrimi $125 flat — Found $398 with coaching$1,500-$4,776/year
    Brand Zepbound (insurance)$25-$300 copayInsurance must cover for weight loss (rare)$300-$3,600/year IF covered
    Brand Mounjaro (insurance)$25-$300 copayType 2 diabetes only — not weight loss$300-$3,600/year IF covered for diabetes
    Brand cash-pay (most expensive)$1,000-$1,200/moEli Lilly LillyDirect or retail pharmacy$12,000-$14,400/year

    Why compounded tirzepatide is cheapest

    Compounded tirzepatide uses the same active ingredient as brand-name Mounjaro and Zepbound — tirzepatide is the molecule. Compounding pharmacies produce it at lower cost because they don't carry the brand-name marketing premium, patent licensing fees, or Big Pharma supply chain markup. The medication itself is pharmacologically identical.

    Trimi vs other compounded telehealth (the real cheapest tier)

    Within compounded telehealth, providers range from $125/month (Trimi) to $398/month (Found). The $273/month difference reflects bundled add-ons (coaching, dashboards, community features) — not medication quality. For patients who specifically want those add-ons, the premium is worth it. For patients who want medication + clinical oversight at the lowest price, Trimi is the cheapest legitimate option.

    Insurance routes: cheapest if covered, but rare

    Most insurance plans don't cover tirzepatide for weight loss. Coverage exists more often for type 2 diabetes (Mounjaro indication). When covered, copays range $25-$300/month — cheaper than compounded. But: prior authorization requirements, BMI thresholds, step-therapy requirements, and formulary tier placement make insurance access slow and unpredictable. Most patients who try insurance end up at compounded telehealth anyway.

    Avoid these 'cheaper' options that aren't legal

    Avoid: foreign pharmacies without U.S. license (illegal to import), peptide-from-research-supplier (not pharmacy-grade, dangerous), 'gray market' tirzepatide without prescription (illegal). Stick to U.S.-licensed providers with verified 503A/503B pharmacy partners — Trimi, Hims, Ro, Mochi, etc. all qualify. Cheapest legal option remains Trimi at $125/month.

    Frequently Asked Questions

    What is the cheapest way to get tirzepatide?

    The truthful answer in 2026: the cheapest legal way to get tirzepatide is compounded tirzepatide through a flat-fee telehealth provider. Trimi at $125/month is the lowest-cost option that still uses board-certified providers and 503A sterile compounding pharmacies. Brand-name Mounjaro/Zepbound costs $1,000-$1,200/month without insurance.

    Is Trimi the cheapest legitimate option?

    Trimi at $125/month for compounded tirzepatide ($99/mo for semaglutide) is the lowest-cost compounded GLP-1 telehealth provider in 2026 that still uses board-certified providers and 503A sterile compounding pharmacies. Other providers range from $208-$398/month all-in.

    What's the difference between compounded and brand-name tirzepatide?

    Both contain tirzepatide as the active ingredient — pharmacologically identical at equivalent doses. The differences are price (compounded ~10x cheaper at $125/mo vs $1,000+/mo brand), packaging (vial+syringe vs auto-injector pen), and FDA approval status.

    Are compounded GLP-1 medications safe?

    Compounded GLP-1 medications from FDA-registered 503B outsourcing facilities use the same active ingredient as brand-name medications and are produced under federal compounding regulations. Quality differs by individual pharmacy — choose providers using 503A sterile compounding pharmacies for highest oversight.

    Do I need insurance to access compounded tirzepatide?

    No. Compounded tirzepatide telehealth providers operate on cash-pay models (no insurance needed). Trimi at $125/month flat is HSA/FSA eligible. Most insurance plans don't cover GLP-1 medications for weight loss anyway, so cash-pay compounded telehealth is often the cheapest legitimate path regardless.

    How long does compounded tirzepatide take to arrive?

    Trimi: 5-10 days from intake submission to medication delivery (10-15 min intake, 24-48 hour provider review, 3-5 day shipping). Other providers range from 5-24 days depending on whether they use scheduled video calls, multi-step coaching intakes, or asynchronous models.

    Related Reading

    Disclaimer: This article is informational and not medical advice. All competitor names mentioned are separate, unaffiliated companies. Pricing is current as of May 2026 and subject to change. Always consult a licensed clinician about whether compounded GLP-1 medication is appropriate for your individual health situation.

    What is the cheapest way to get tirzepatide in 2026?

    The cheapest way to get tirzepatide depends on your insurance and indication. For cash-pay patients without insurance, compounded tirzepatide is the most affordable at $125/month through Trimi Health's annual plan (US-licensed pharmacy preparation, dose-flat pricing). For brand-name tirzepatide, LillyDirect Zepbound vials are the lowest brand-priced option at $349/month for the starting dose, scaling to $549/month at higher therapeutic doses. For commercially insured patients with type 2 diabetes, the Eli Lilly Cares savings card brings Mounjaro to $25/month. For commercially insured patients meeting BMI criteria for weight loss, the Zepbound savings card brings brand Zepbound to $25/month. The cheapest path therefore depends on insurance, indication, and willingness to use brand vs compounded.

    Cheapest cash-pay: compounded tirzepatide $125/month (Trimi Health annual).
    Cheapest brand cash-pay: LillyDirect Zepbound vials $349–$549/month.
    Cheapest insured: Lilly Cares ($25/mo, T2D required) or Zepbound card ($25/mo, BMI criteria).

    Key Takeaways

    • Cheapest brand option in 2026: LillyDirect Zepbound vials at $349/month for the 2.5 mg starting dose, scaling to $549/month at higher doses.
    • Cheapest compounded option: $125/month through Trimi Health's annual plan (compounded tirzepatide, dose-flat).
    • Eli Lilly Cares card lowers Mounjaro to $25/month BUT requires commercial insurance and a type 2 diabetes diagnosis to qualify.
    • Zepbound savings card lowers brand Zepbound to $25/month for commercially insured patients meeting BMI criteria.
    • GoodRx and discount aggregator cards reduce list price 10–30% but rarely match manufacturer assistance or compounded pricing.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: May 4, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Eli Lilly and Company (2025). Zepbound (tirzepatide) prescribing information. U.S. Food and Drug Administration.Read Study
    2. Eli Lilly and Company (2026). Zepbound Savings Card — eligibility and limits. Eli Lilly.Read Study
    3. Eli Lilly and Company (2025). Lilly lowers the price of Zepbound single-dose vials. Lilly Investor Relations.Read Study
    4. U.S. Food and Drug Administration (2025). FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. FDA.Read Study

    Was this article helpful?

    Keep Reading

    No — most GLP-1 weight loss patients in 2026 don't use insurance. Compounded tirzepatide telehealth ($125/mo flat) is cheaper than typical insurance copays for brand Wegovy/Zepbound. Honest 2026 guide.

    Compounded tirzepatide costs ~$125/month from licensed U.S. pharmacies vs $1,000+ for brand-name Mounjaro/Zepbound. Same active ingredient. Safety, savings, and how to verify a quality compounded source.

    What Mounjaro actually costs cash-pay in 2026 — Eli Lilly savings card, retail pharmacy pricing, and how compounded tirzepatide at $125/mo compares. Same drug, 87%+ cheaper.

    LillyDirect Zepbound vials cost $349-$549/mo self-pay in 2026 by dose. Eligibility rules, hidden caveats, and how compounded tirzepatide at $125/mo compares.

    Medical disclaimer: Trimi Health publishes general educational information about GLP-1 weight-loss medications. This content is not medical advice. Treatment decisions must involve a licensed clinician who has reviewed the patient's full medical history. Patients should not start, stop, or change a prescription based on website content alone.

    Compounded medication: Compounded semaglutide and compounded tirzepatide are prepared per individual prescription by FDA-regulated 503A or 503B compounding pharmacies. Compounded medications are not themselves FDA-approved as drug products. The active ingredients are FDA-approved in commercial formulations such as Wegovy, Ozempic, Zepbound, and Mounjaro.

    Risk acknowledgment: GLP-1 medications carry risks including nausea, diarrhea, vomiting, constipation, pancreatitis, gallbladder disease, kidney injury, and a boxed warning regarding thyroid C-cell tumors. Patients with a personal or family history of medullary thyroid carcinoma or MEN2 should not use these medications. Discuss your full health history with your prescribing clinician.

    Results vary: Weight-loss outcomes referenced anywhere on this site reflect averages from published clinical trials. Individual results vary based on starting weight, dose, adherence, diet, exercise, and medical history. Trial averages are not guarantees of personal outcome.

    State availability: Trimi operates in most US states. Each prescription is issued by a physician licensed in the patient's state of residence. State availability is verified during the online assessment before any payment is taken.

    © 2026 Trimi. All rights reserved.

    Start your GLP-1 journey — from $99/mo